Health Sciences Acquisitions Corp 2 FY 2022: revenue $3.5M; diluted EPS −$0.17

Key figures from this report

These are the numbers Health Sciences Acquisitions Corp 2 reported for the year ended Dec 31, 2022, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

1. Revenue$3.5MNo year-earlier figure tagged10-K income statement, on EDGAR
2. Net income−$2.7MAgainst −$379K in FY 202110-K income statement, on EDGAR
3. Diluted EPS−$0.17Against −$0.02 in FY 202110-K income statement, on EDGAR
4. Cash and cash equivalents$175K−90% from $1.8M in FY 2021Cash and equivalents only; the company page adds short-term investments.10-K balance sheet, on EDGAR
5. Cash from operations−$1.6MAgainst −$272K in FY 202110-K cash flow statement, on EDGAR

Every year in the financial tables